Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M402Revenue (TTM) $M144Net Margin (%)-105.2Altman Z-Score-18.8
Enterprise Value $M596EPS (TTM) $-1.2Operating Margin %-76.3Piotroski F-Score3
P/E(ttm)--Beneish M-Score-0.3Pre-tax Margin (%)-106.4Higher ROA y-yY
Price/Book--10-y EBITDA Growth Rate %--Quick Ratio0.5Cash flow > EarningsN
Price/Sales2.75-y EBITDA Growth Rate %-27.6Current Ratio0.7Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-97.6Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M131ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with MACK

Number of guru portfolios checked: 69.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

MACK is held by these investors:



MACK: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Schoeberl Birgit M.Head of Discovery 2016-07-25Sell50,000$5.5-44view
PORTER MICHAEL EDirector 2016-03-17Buy5,000$7.2-57.22view
PORTER MICHAEL EDirector 2016-03-15Buy5,000$7.65-59.74view
PORTER MICHAEL EDirector 2016-03-08Buy10,000$7.09-56.56view
PORTER MICHAEL EDirector 2016-03-03Buy15,000$6.39-51.8view
PORTER MICHAEL EDirector 2016-03-01Buy20,000$6.11-49.59view
Lee Vivian SDirector 2016-02-29Buy35,000$5.5-44view
McClements William M.Head of Corporate Operations 2016-02-29Buy2,000$5.72-46.15view
Stewart Edward J.Head of Commercial 2016-01-05Sell4,000$8-61.5view
Stewart Edward J.Head of Commercial 2015-12-01Sell5,000$9.33-66.99view

Quarterly/Annual Reports about MACK:

    News about MACK:

    Articles On GuruFocus.com
    Weekly CEO Sells Highlight: Starbucks Corp, KD Supply Holdings Inc, Capital One Financial Corp, Merr Dec 14 2014 

    More From Other Websites
    Merrimack to Present at the 2017 American Association for Cancer Research Annual Meeting Mar 27 2017
    Merrimack (MACK) Starts Enrollment in Solid Tumors Study Mar 24 2017
    ​Merrimack asset sale prompts legal blowback Mar 23 2017
    Merrimack Initiates Phase 1 Study of MM-310 in Solid Tumors Mar 23 2017
    Lawyer: former Merrimack employee accused of insider trading to fight charges Mar 22 2017
    Merrimack Pharmaceuticals, Inc. :MACK-US: Earnings Analysis: Q4, 2016 By the Numbers : March 15,... Mar 15 2017
    Merrimack Pharmaceuticals, Inc. :MACK-US: Earnings Analysis: 2016 By the Numbers : March 14, 2017 Mar 14 2017
    Biotech's Fall as President Trump to Address Pricing Concerns: Today's Research Reports on Arena... Mar 08 2017
    MERRIMACK PHARMACEUTICALS INC Financials Mar 07 2017
    Merrimack (MACK) Q4 Loss Lower than Expected, Revenues Top Mar 02 2017
    These 5 Stocks Under $10 Could Explode Up Soon Mar 02 2017
    Edited Transcript of MACK earnings conference call or presentation 1-Mar-17 1:30pm GMT Mar 01 2017
    MERRIMACK PHARMACEUTICALS INC Files SEC form 10-K, Annual Report Mar 01 2017
    Merrimack's (MACK) Q4 Loss In-Line With Estimates Mar 01 2017
    Merrimack reports 4Q loss Mar 01 2017
    Merrimack reports 4Q loss Mar 01 2017
    Q4 2016 Merrimack Pharmaceuticals Inc Earnings Release - Before Market Open Mar 01 2017
    Merrimack Reports Fourth Quarter and Full-Year 2016 Financial Results Mar 01 2017
    Merrimack Announces Timing of Fourth Quarter 2016 Investor Conference Call Feb 22 2017
    Merrimack (MACK): What Awaits the Stock in Q4 Earnings? Feb 17 2017

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)